{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:27:24Z","timestamp":1792099644088,"version":"4.4.0"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is limited evidence of financial toxicity (FT) among cancer patients from countries of various income levels. Hence, this study aimed to determine the prevalence of objective and subjective FT and their measurements in relation to cancer treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Science Direct, Scopus, and CINAHL databases were searched to find studies that examined FT. There was no limit on the design or setting of the study. Random-effects meta-analysis was utilized to obtain the pooled prevalence of objective FT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 244 identified studies during the initial screening, only 64 studies were included in this review. The catastrophic health expenditure (CHE) method was often used in the included studies to determine the objective FT. The pooled prevalence of CHE was 47% (95% CI: 24.0\u201370.0) in middle- and high-income countries, and the highest percentage was noted in low-income countries (74.4%). A total of 30 studies focused on subjective FT, of which 9 used the Comprehensive Score for FT (COST) tool and reported median scores ranging between 17.0 and 31.9.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study shows that cancer patients from various income-group countries experienced a significant financial burden during their treatment. It is imperative to conduct further studies on interventions and policies that can lower FT caused by cancer treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2023.1266533","type":"journal-article","created":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T23:11:50Z","timestamp":1704150710000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Describing financial toxicity among cancer patients in different income countries: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"11","author":[{"given":"Meram","family":"Azzani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahib Mohammed","family":"Atroosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Anbazhagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinoth","family":"Kumarasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Mohamed Ibrahim","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"ref1","volume-title":"Global Cancer observatory: Cancer today","author":"Ferlay","year":"2020"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"ref3","first-page":"1675","article-title":"Inequality in the incidence and mortality of all cancers in the world","volume":"45","author":"Ghoncheh","year":"2016","journal-title":"Iran J Public Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","article-title":"International incidence of childhood cancer, 2001-10: a population-based registry study","volume":"18","author":"Steliarova-Foucher","year":"2017","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-78649-0_1","article-title":"Outlining the crisis in Cancer care","volume-title":"Quality Cancer care: Survivorship before, during and after treatment","author":"Milroy","year":"2018"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3322\/caac.21443","article-title":"The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment","volume":"68","author":"Carrera","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"100269","DOI":"10.1016\/j.eclinm.2020.100269","article-title":"Financial toxicity of cancer treatment: moving the discussion from acknowledgement of the problem to identifying solutions","volume":"20","author":"Desai","year":"2020","journal-title":"EClinicalMedicine"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/annonc\/mdz140","article-title":"Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications","volume":"30","author":"Witte","year":"2019","journal-title":"Ann Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/jso.25374","article-title":"Financial toxicity in cancer care: prevalence, causes, consequences, and reduction strategies","volume":"120","author":"Lentz","year":"2019","journal-title":"J Surg Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"djv370","DOI":"10.1093\/jnci\/djv370","article-title":"Financial toxicity of Cancer care: It's time to intervene","volume":"108","author":"Zafar","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"djv410","DOI":"10.1093\/jnci\/djv410","article-title":"Minimizing the \"financial toxicity\" associated with cancer care: advancing the research agenda","volume":"108","author":"Tucker-Seeley","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e2025810","DOI":"10.1001\/jamanetworkopen.2020.25810","article-title":"Assessment of financial toxicity among older adults with advanced Cancer","volume":"3","author":"Arastu","year":"2020","journal-title":"JAMA Netw Open"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40271-016-0204-x","article-title":"A systematic review of financial toxicity among Cancer survivors: we Can't pay the co-pay","volume":"10","author":"Gordon","year":"2017","journal-title":"Patient"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1002\/hed.26801","article-title":"The cost of cure: examining objective and subjective financial toxicity in head and neck cancer survivors","volume":"43","author":"Baddour","year":"2021","journal-title":"Head Neck"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1377\/hlthaff.2012.1263","article-title":"Washington state cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis","volume":"32","author":"Ramsey","year":"2013","journal-title":"Health Aff (Millwood)."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1200\/JCO.2015.64.6620","article-title":"Financial insolvency as a risk factor for early mortality among patients with Cancer","volume":"34","author":"Ramsey","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1007\/s00520-022-07044-z","article-title":"Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis","volume":"30","author":"Donkor","year":"2022","journal-title":"Support Care Cancer"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.1007\/s00520-020-05719-z","article-title":"Financial toxicity and employment status in cancer survivors. A systematic literature review","volume":"28","author":"Mols","year":"2020","journal-title":"Support Care Cancer"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/pubmed\/fdt032","article-title":"Measuring current and future cost of skin cancer in England","volume":"36","author":"Vallejo-Torres","year":"2014","journal-title":"J Public Health (Oxf)"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10198-019-01157-9","article-title":"A general framework for classifying costing methods for economic evaluation of health care","volume":"21","author":"\u0160pac\u00edrov\u00e1","year":"2020","journal-title":"Eur J Health Econ"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/resp.12783","article-title":"Introduction to systematic reviews and meta-analysis","volume":"21","author":"McKenzie","year":"2016","journal-title":"Respirology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s11136-019-02150-8","article-title":"Relationship between paid leave, financial burden, and patient-reported outcomes among employed patients who have undergone bone marrow transplantation","volume":"28","author":"Albelda","year":"2019","journal-title":"Qual Life Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1007\/s00520-021-06697-6","article-title":"Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment","volume":"30","author":"Aviki","year":"2022","journal-title":"Support Care Cancer"},{"key":"ref26","first-page":"1","article-title":"Perceived economic hardship and distress in acute myelogenous Leukemia","volume":"8","author":"Bala-Hampton","year":"2017","journal-title":"J. Oncol. Navigation Survivorship"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1377\/hlthaff.2015.0830","article-title":"For working-age Cancer survivors, medical debt and bankruptcy create financial hardships","volume":"35","author":"Banegas","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jpainsymman.2017.12.335","article-title":"Chemotherapy use, end-of-life care, and costs of care among patients diagnosed with stage IV pancreatic Cancer","volume":"55","author":"Bao","year":"2018","journal-title":"J Pain Symptom Manag"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.juro.2017.10.049","article-title":"Financial toxicity among patients with bladder Cancer: reasons for delay in care and effect on quality of life","volume":"199","author":"Casilla-Lennon","year":"2018","journal-title":"J Urol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00520-018-4418-4","article-title":"\"it still affects our economic situation\": long-term economic burden of breast cancer and lymphedema","volume":"27","author":"Dean","year":"2019","journal-title":"Support Care Cancer"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"76e1","DOI":"10.1016\/j.urolonc.2020.09.030","article-title":"A national cross-sectional survey of financial toxicity among bladder cancer patients","volume":"39","author":"Ehlers","year":"2021","journal-title":"Urol Oncol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"494","DOI":"10.15585\/mmwr.mm6822a2","article-title":"Annual out-of-pocket expenditures and financial hardship among cancer survivors aged 18\u201364 years\u2014United States, 2011\u20132016","volume":"68","author":"Ekwueme","year":"2019","journal-title":"Morb Mortal Wkly Rep"},{"key":"ref33","first-page":"801","article-title":"The personal financial burden of cancer for the working-aged population","volume":"15","author":"Finkelstein","year":"2009","journal-title":"Am J Manag Care"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3111\/13696998.2016.1138962","article-title":"The economic burden of brain metastasis among lung cancer patients in the United States","volume":"19","author":"Gu\u00e9rin","year":"2016","journal-title":"J Med Econ"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1200\/JCO.2013.49.1241","article-title":"Economic burden of cancer survivorship among adults in the United States","volume":"31","author":"Guy","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11764-019-00772-y","article-title":"Financial burden of cancer care under the affordable care act: analysis of MEPS-experiences with cancer survivorship 2011 and 2016","volume":"13","author":"Hong","year":"2019","journal-title":"J Cancer Surviv"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.1016\/S2352-3026(15)00151-9","article-title":"Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study","volume":"2","author":"Huntington","year":"2015","journal-title":"Lancet Haematol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"100312","DOI":"10.1016\/j.jcpo.2021.100312","article-title":"Low-value care and excess out-of-pocket expenditure among older adults with incident cancer\u2013a machine learning approach","volume":"30","author":"Iloabuchi","year":"2021","journal-title":"J Cancer Policy"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2217\/fon-2021-1282","article-title":"Financial toxicity and its impact on health outcomes and caregiver burden among adult cancer survivors in the USA","volume":"18","author":"Inguva","year":"2022","journal-title":"Future Oncol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1200\/JCO.2013.53.0956","article-title":"Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries","volume":"32","author":"Jagsi","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/cncr.29808","article-title":"Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors","volume":"122","author":"Kale","year":"2016","journal-title":"Cancer"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jhep.2008.07.029","article-title":"The burden of illness associated with hepatocellular carcinoma in the United States","volume":"50","author":"Lang","year":"2009","journal-title":"J Hepatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1001\/jamaoto.2018.3982","article-title":"Comparison of the financial burden of survivors of head and neck Cancer with other Cancer survivors","volume":"145","author":"Massa","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"105881","DOI":"10.1016\/j.ypmed.2019.105881","article-title":"Financial hardship among rural cancer survivors: an analysis of the medical expenditure panel survey","volume":"129","author":"Odahowski","year":"2019","journal-title":"Prev Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jpainsymman.2019.05.011","article-title":"Financial strain and physical and emotional quality of life in breast cancer","volume":"58","author":"Perry","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"ref46","volume-title":"Financial toxicity among women with metastatic breast Cancer. Oncology nursing forum","author":"Rosenzweig","year":"2019"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.whi.2004.11.006","article-title":"Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population","volume":"15","author":"Sasser","year":"2005","journal-title":"Womens Health Issues"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/S0149-2918(99)80037-X","article-title":"The economic burden associated with colon cancer in the United States","volume":"21","author":"Seifeldin","year":"1999","journal-title":"Clin Ther"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1200\/JCO.2011.37.9511","article-title":"Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis","volume":"30","author":"Shankaran","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1200\/JCO.2017.77.6310","article-title":"Financial impact of breast Cancer in black versus white women","volume":"36","author":"Wheeler","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11764-015-0470-y","article-title":"Predictors of financial difficulties and work modifications among cancer survivors in the United States","volume":"10","author":"Whitney","year":"2016","journal-title":"J Cancer Surviv"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1200\/JCO.2015.62.0468","article-title":"Financial hardship associated with Cancer in the United States: findings from a population-based sample of adult Cancer survivors","volume":"34","author":"Yabroff","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"djv382","DOI":"10.1093\/jnci\/djv382","article-title":"Annual medical expenditure and productivity loss among colorectal, female breast, and prostate cancer survivors in the United States","volume":"108","author":"Zheng","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.lungcan.2018.06.007","article-title":"Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: a retrospective observational study (LuCaBIS)","volume":"124","author":"Andreas","year":"2018","journal-title":"Lung Cancer"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1007\/s00520-020-05890-3","article-title":"Breast cancer-related lymphedema and its treatment: how big is the financial impact?","volume":"29","author":"De Vrieze","year":"2021","journal-title":"Support Care Cancer"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00520-020-05508-8","article-title":"A cost analysis of a community-based support Centre for cancer patients and their families in Ireland: the EVeCANs study","volume":"29","author":"Murphy","year":"2021","journal-title":"Support Care Cancer"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1007\/s00520-017-3683-y","article-title":"Counting the cost of cancer: out-of-pocket payments made by colorectal cancer survivors","volume":"25","author":"\u00d3 C\u00e9illeachair","year":"2017","journal-title":"Support Care Cancer"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11764-018-0723-7","article-title":"Financial toxicity is more than costs of care: the relationship between employment and financial toxicity in long-term cancer survivors","volume":"13","author":"Pearce","year":"2019","journal-title":"J Cancer Surviv"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/DCR.0000000000000923","article-title":"Financial impact of colorectal cancer and its consequences: associations between cancer-related financial stress and strain and health-related quality of life","volume":"61","author":"Sharp","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0959-8049(01)00292-1","article-title":"The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up","volume":"37","author":"van Agthoven","year":"2001","journal-title":"Eur J Cancer"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.bjoms.2011.07.026","article-title":"Patients' perception of the financial impact of head and neck cancer and the relationship to health related quality of life","volume":"50","author":"Rogers","year":"2012","journal-title":"Br J Oral Maxillofac Surg"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00520-015-2832-4","article-title":"Pre-diagnosis employment status and financial circumstances predict cancer-related financial stress and strain among breast and prostate cancer survivors","volume":"24","author":"Sharp","year":"2016","journal-title":"Support Care Cancer"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11764-013-0305-7","article-title":"Patient time and out-of-pocket costs for long-term prostate cancer survivors in Ontario","volume":"8","author":"de Oliveira","year":"2014","journal-title":"Canada J Cancer Surviv"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/curroncol28010005","article-title":"Out-of-pocket costs and perceived financial burden associated with prostate Cancer treatment in a Quebec remote area: a cross-sectional study","volume":"28","author":"El-Haouly","year":"2020","journal-title":"Curr Oncol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.3390\/curroncol29040223","article-title":"The economic burden of Cancer in Canada from a societal perspective","volume":"29","author":"Garaszczuk","year":"2022","journal-title":"Curr Oncol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/jnci\/djs512","article-title":"Out-of-pocket costs in the year after early breast cancer among Canadian women and spouses","volume":"105","author":"Lauzier","year":"2013","journal-title":"J National Cancer Institute"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1007\/s00520-016-3283-2","article-title":"Financial burden of colorectal cancer treatment among patients and their families in a middle-income country","volume":"24","author":"Azzani","year":"2016","journal-title":"Support Care Cancer"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.31557\/APJCP.2020.21.10.3077","article-title":"Assessing the relationship between socio-demographic, clinical profile and financial toxicity: evidence from Cancer survivors in Sarawak","volume":"21","author":"Yap","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00520-019-04975-y","article-title":"Financial toxicity and its associations with health-related quality of life among urologic cancer patients in an upper middle-income country","volume":"28","author":"Ting","year":"2020","journal-title":"Support Care Cancer"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1177\/1010539517732224","article-title":"Catastrophic health expenditure among colorectal Cancer patients and families: a case of Malaysia","volume":"29","author":"Azzani","year":"2017","journal-title":"Asia Pacific J Public Health"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/ajco.13508","article-title":"Measuring financial toxicity in Australian cancer patients\u2013validation of the Comprehensive score for financial toxicity (FACT COST) measuring financial toxicity in Australian cancer patients","volume":"17","author":"Durber","year":"2021","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/ajco.13180","article-title":"The patient co-payment and opportunity costs of accessing healthcare for indigenous Australians with cancer: a whole of population data linkage study","volume":"15","author":"Callander","year":"2019","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"106786","DOI":"10.1016\/j.leukres.2022.106786","article-title":"Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system","volume":"113","author":"Parker","year":"2022","journal-title":"Leuk Res"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.12392","article-title":"Financial toxicity: a potential side effect of prostate cancer treatment among Australian men","volume":"26","author":"Gordon","year":"2017","journal-title":"Eur J Cancer Care (Engl)"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.12744","article-title":"Reduced employment and financial hardship among middle-aged individuals with colorectal cancer","volume":"26","author":"Gordon","year":"2017","journal-title":"Eur J Cancer Care (Engl)"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/pon.1182","article-title":"Exploring the economic impact of breast cancers during the 18 months following diagnosis","volume":"16","author":"Gordon","year":"2007","journal-title":"Psychooncology"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12913-021-06246-1","article-title":"Cutaneous melanoma: cost of illness under Brazilian health system perspectives","volume":"21","author":"da Veiga","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1590\/S0365-05962011000400005","article-title":"An estimate of the cost of treating non-melanoma skin cancer in the state of S\u00e3o Paulo, Brazil","volume":"86","author":"Souza","year":"2011","journal-title":"An Bras Dermatol"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12939-017-0675-y","article-title":"Financial burden of healthcare for cancer patients with social medical insurance: a multi-centered study in urban China","volume":"16","author":"Mao","year":"2017","journal-title":"Int J Equity Health"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00520-017-3949-4","article-title":"Objective and subjective financial burden and its associations with health-related quality of life among lung cancer patients","volume":"26","author":"Chen","year":"2018","journal-title":"Support Care Cancer"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vhri.2021.02.005","article-title":"Economic burden of Gynecological cancers in Iran","volume":"28","author":"Sargazi","year":"2022","journal-title":"Value Health Reg Issues"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"100228","DOI":"10.1016\/j.jcpo.2020.100228","article-title":"Hospitalization costs of breast cancer before and after the implementation of the health sector evolution plan (HSEP), Iran, 2017: a retrospective single-centre study","volume":"24","author":"Afkar","year":"2020","journal-title":"J Cancer Policy"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.31557\/APJCP.2019.20.7.2131","article-title":"The economic burden of breast Cancer survivors in Korea: a descriptive study using a 26-month Micro-costing cohort approach","volume":"20","author":"You","year":"2019","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0929-6646(08)60008-X","article-title":"Estimation of the financial burden to the National Health Insurance for patients with major cancers in Taiwan","volume":"107","author":"Chu","year":"2008","journal-title":"J Formos Med Assoc"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JGO.19.00003","article-title":"Prospective survey of financial toxicity measured by the comprehensive score for financial toxicity in Japanese patients with Cancer","volume":"5","author":"Honda","year":"2019","journal-title":"J Glob Oncol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1186\/s12889-020-09137-y","article-title":"Catastrophic healthcare expenditure and coping strategies among patients attending cancer treatment services in Addis Ababa, Ethiopia","volume":"20","author":"Kasahun","year":"2020","journal-title":"BMC Public Health"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1377\/hlthaff.5.4.138","article-title":"A look at catastrophic medical expenses and the poor","volume":"5","author":"Berki","year":"1986","journal-title":"Health Aff (Millwood)."},{"key":"ref88","volume-title":"Distribution of health payments and catastrophic expenditures methodology\/by Ke Xu","year":"2005"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0140-6736(03)13861-5","article-title":"Household catastrophic health expenditure: a multicountry analysis","volume":"362","author":"Xu","year":"2003","journal-title":"Lancet"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/hec.776","article-title":"Catastrophe and impoverishment in paying for health care: with applications to Vietnam 1993-1998","volume":"12","author":"Wagstaff","year":"2003","journal-title":"Health Econ"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.3390\/cancers13195015","article-title":"Patient-reported financial distress in Cancer: a systematic review of risk factors in universal healthcare systems","volume":"13","author":"Pauge","year":"2021","journal-title":"Cancers (Basel)"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1002\/cncr.28814","article-title":"The development of a financial toxicity patient-reported outcome in cancer: the COST measure","volume":"120","author":"de Souza","year":"2014","journal-title":"Cancer"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1266533\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T23:11:57Z","timestamp":1704150717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1266533\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":92,"alternative-id":["10.3389\/fpubh.2023.1266533"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1266533","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"article-number":"1266533"}}